Statistics for Immunogenicity and Tolerability of an MF59-adjuvanted, Egg-derived, A/H1N1 Pandemic Influenza Vaccine in Children 6-35 Months of Age
Total visits
| views | |
|---|---|
| Immunogenicity and Tolerability of an MF59-adjuvanted, Egg-derived, A/H1N1 Pandemic Influenza Vaccine in Children 6-35 Months of Age | 83 |
Total visits per month
| views | |
|---|---|
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 0 |
| August 2024 | 0 |
| September 2024 | 0 |
| October 2024 | 0 |
| November 2024 | 0 |
File Visits
| views | |
|---|---|
| Immunogenicity and Tolerability of an MF59-adjuvanted, Egg-derived, A:H1N1 Pandemic Influenza Vaccine in Children 6-35 Months of Age.pdf | 19 |
Top country views
| views | |
|---|---|
| United States | 41 |
| Chile | 21 |
| Mexico | 1 |
Top city views
| views | |
|---|---|
| Miami | 37 |
| Santiago | 18 |
| Concepcion | 3 |
| Alameda | 2 |
| Campbell | 1 |
| Sacramento | 1 |
| Zapopan | 1 |